Trial Search Results

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

The primary objective is to determine if pre-operative transversus abdominis plane (TAP) nerve blocks by continued infusion of local anesthetic post-operatively affects post-operative narcotic usage, as compared to a placebo TAP block, after breast reconstruction surgery.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: Transversus Abdominis Plane (TAP) block
  • Device: Nimbus Infusion Pump IV Administration
  • Drug: Bupivacaine infusion
  • Drug: Acetominophen
  • Drug: Hydromorphone
  • Drug: Oxycodone
  • Drug: Ondansetron

Phase:

Phase 3

Eligibility


Inclusion Criteria

   - Prior diagnosis or presumed diagnosis of breast cancer or undergoing prophylactic
   treatment.

   - Greater than 18 years old.

   - Female.

   - Undergoing microsurgical breast reconstruction with abdominal free flap.

   - Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

   - True allergy to local anesthetics or opioids.

   - History of addiction to narcotics within the last 24 months

   - History of chronic pain on opioids within the last 24 months.

   - Specific mental health issues such as schizophrenia or bipolar disorder.

   - Patients who are pregnant.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Afaaf Shakir